These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 19857106)
1. Intraocular pressure (IOP) reduction by latanoprost in Japanese normal tension glaucoma patients over a five-year period stratified by presenting IOP. Tsuda M; Ando A; Matsuyama K; Otsuji T; Fukui C; Maenishi N; Kuwahara A; Nishimura T; Jo N; Nambu H; Matsumura M J Ocul Pharmacol Ther; 2009 Oct; 25(5):441-5. PubMed ID: 19857106 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma. Sato S; Hirooka K; Baba T; Mizote M; Fujimura T; Tenkumo K; Ueda H; Shiraga F J Ocul Pharmacol Ther; 2011 Oct; 27(5):499-502. PubMed ID: 21790301 [TBL] [Abstract][Full Text] [Related]
3. A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients. Tomita G; Araie M; Kitazawa Y; Tsukahara S Eye (Lond); 2004 Oct; 18(10):984-9. PubMed ID: 15037889 [TBL] [Abstract][Full Text] [Related]
4. Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma. Ishibashi S; Hirose N; Tawara A; Kubota T J Glaucoma; 2006 Oct; 15(5):354-7. PubMed ID: 16988595 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Ocular Pulse Amplitude-Lowering Effects of Tafluprost and Latanoprost by Dynamic Contour Tonometry. Park SH; Yoo SH; Ha SJ J Ocul Pharmacol Ther; 2015 Dec; 31(10):617-22. PubMed ID: 26348718 [TBL] [Abstract][Full Text] [Related]
6. Additional reduction in intraocular pressure achieved with latanoprost in normal-tension glaucoma patients previously treated with unoprostone. Enoki M; Saito J; Hara M; Uchida T; Sagara T; Nishida T Jpn J Ophthalmol; 2006; 50(4):334-337. PubMed ID: 16897217 [TBL] [Abstract][Full Text] [Related]
7. The effect of latanoprost on intraocular pressure during 12 months of treatment for normal-tension glaucoma. Oh JY; Park KH Korean J Ophthalmol; 2005 Dec; 19(4):297-301. PubMed ID: 16491821 [TBL] [Abstract][Full Text] [Related]
8. Effects of switching from topical beta-blockers to latanoprost on intraocular pressure in patients with normal-tension glaucoma. Ikeda Y; Mori K; Ishibashi T; Naruse S; Nakajima N; Kinoshita S J Ocul Pharmacol Ther; 2008 Apr; 24(2):230-4. PubMed ID: 18341431 [TBL] [Abstract][Full Text] [Related]
9. Degree of angle closure and the intraocular pressure-lowering effect of latanoprost in subjects with chronic angle-closure glaucoma. Aung T; Chan YH; Chew PT; Ophthalmology; 2005 Feb; 112(2):267-71. PubMed ID: 15691562 [TBL] [Abstract][Full Text] [Related]
10. Hypotensive effect of latanoprost/timolol versus travoprost/timolol fixed combinations in NTG patients: a randomized, multicenter, crossover clinical trial. Shoji T; Sato H; Mizukawa A; Hirota N; Enoki T; Kojima T; Kanda T; Takeuchi M Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6242-7. PubMed ID: 23950156 [TBL] [Abstract][Full Text] [Related]
11. Clinical experience in the treatment of normal tension glaucoma with latanoprost in Germany. Thelen U; Weiler W; Kirchhoff E; Fuchs HB; Stewart WC J Ocul Pharmacol Ther; 2007 Jun; 23(3):311-3. PubMed ID: 17593016 [TBL] [Abstract][Full Text] [Related]
12. Long-term effect of latanoprost on central corneal thickness in normal tension glaucoma. Kim HJ; Cho BJ J Ocul Pharmacol Ther; 2011 Feb; 27(1):73-6. PubMed ID: 21091278 [TBL] [Abstract][Full Text] [Related]
13. The circadian changes of intraocular pressure and ocular perfusion pressure after tafluprost compared with travoprost in normal tension glaucoma. Shin J; Lee JW; Choi BS; Yun EY; Jung JH; Kim EA; Caprioli J J Ocul Pharmacol Ther; 2014 Dec; 30(10):803-9. PubMed ID: 25285367 [TBL] [Abstract][Full Text] [Related]
14. Correlation between individual differences in intraocular pressure reduction and outflow facility due to latanoprost in normal-tension glaucoma patients. Kondo N; Sawada A; Yamamoto T; Taniguchi T Jpn J Ophthalmol; 2006; 50(1):20-4. PubMed ID: 16453183 [TBL] [Abstract][Full Text] [Related]
15. Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study. Katz LJ; Rauchman SH; Cottingham AJ; Simmons ST; Williams JM; Schiffman RM; Hollander DA Curr Med Res Opin; 2012 May; 28(5):781-8. PubMed ID: 22458918 [TBL] [Abstract][Full Text] [Related]
16. Double-masked, randomized, dose-response study of AR-13324 versus latanoprost in patients with elevated intraocular pressure. Bacharach J; Dubiner HB; Levy B; Kopczynski CC; Novack GD; Ophthalmology; 2015 Feb; 122(2):302-7. PubMed ID: 25270273 [TBL] [Abstract][Full Text] [Related]
17. Comparison of latanoprost and timolol in pediatric glaucoma: a phase 3, 12-week, randomized, double-masked multicenter study. Maeda-Chubachi T; Chi-Burris K; Simons BD; Freedman SF; Khaw PT; Wirostko B; Yan E; Ophthalmology; 2011 Oct; 118(10):2014-21. PubMed ID: 21680022 [TBL] [Abstract][Full Text] [Related]
18. The additive effect of latanoprost to maximum-tolerated medications with low-dose, high-dose, or no pilocarpine therapy. Shin DH; McCracken MS; Bendel RE; Pearlman R; Juzych MS; Hughes BA; Schulz LL; Kim C; Baek NH Ophthalmology; 1999 Feb; 106(2):386-90. PubMed ID: 9951495 [TBL] [Abstract][Full Text] [Related]
19. Effect of concomitant use of latanoprost and brinzolamide on 24-hour variation of IOP in normal-tension glaucoma. Nakamoto K; Yasuda N J Glaucoma; 2007; 16(4):352-7. PubMed ID: 17570997 [TBL] [Abstract][Full Text] [Related]
20. Long-term effects of latanoprost monotherapy on intraocular pressure in Japanese glaucoma patients. Kashiwagi K; Tsumura T; Tsukahara S J Glaucoma; 2008 Dec; 17(8):662-6. PubMed ID: 19092463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]